C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence

Published:2019-03-24 Issue:10 Volume:33 Page:914-923
ISSN:0894-1939
Container-title:Journal of Investigative Surgery
language:en
Short-container-title:Journal of Investigative Surgery

Author:

Chen Jianxu¹,Chen Jiandi²,Gong Yihang¹,Zou Baojia¹,Liu Xialei¹,Ding Lei¹,Huang Jiaxing³,Zhang Baimeng¹,Li Jian¹

Affiliation:

1. Department of Hepatobiliary Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China;

2. Department of Endocrinology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China;

3. Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, China

Funder

Fundamental Research Funds

Publisher

Informa UK Limited

Subject

Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/08941939.2019.1586015

Reference39 articles.

1. Global cancer statistics, 2012

2. Medical therapies for hepatocellular carcinoma: a critical view of the evidence

3. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation

5. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis and experimental validation of a novel autophagy-related signature relevant to immune infiltration for recurrence prediction after curative hepatectomy;Aging;2023-04-03

2. miR-141-3p Reduces Cell Migration and Proliferation in an In Vitro Modelof Atherosclerosis by Targeting Wnt5a;Journal of Investigative Surgery;2021-04-05

3. Role of C14orf166 in viral infection and RNA metabolism and its relationship with cancer (Review);Molecular Medicine Reports;2021-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3